| Symbol | Company | Weighting |
|---|---|---|
| NTRA | NATERA INC | 4.58% |
| INSM | INSMED INC | 4.23% |
| THC | TENET HEALTHCARE CORP | 3.27% |
| ISRG | INTUITIVE SURGICAL INC | 2.81% |
| MASI | MASIMO CORP | 2.76% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 2.76% |
| PCVX | VAXCYTE INC | 2.52% |
| EXEL | EXELIXIS INC | 2.33% |
| ITCI | INTRA-CELLULAR THERAPIES USD | 2.20% |
| SRPT | SAREPTA THERAPEUTICS INC | 2.14% |
| ALNY | ALNYLAM PHARMACEUTICALS INC. | 2.13% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.12% |
| CYTK | CYTOKINETICS INC | 2.08% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 2.06% |
| MCK | MCKESSON CORP | 2.02% |
| HCA | HCA HOLDINGS INC | 1.95% |
| XENE | XENON PHARMACEUTICALS | 1.90% |
| ABBV | ABBVIE INC | 1.89% |
| RVTY | REVVITY INC | 1.85% |
| LLY | ELI LILLY CORP | 1.85% |
| ARGX | ARGENX SE ADR | 1.80% |
| ALKS | ALKERMES INC | 1.79% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.76% |
| COR | CENCORA INC | 1.72% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.67% |
| AVTR | AVANTOR, INC. | 1.67% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.66% |
| DHR | DANAHER CORP | 1.61% |
| DNLI | DENALI THERAPEUTICS INC. | 1.61% |
| BIO | BIO-RAD LABORATORIES INC | 1.53% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.52% |
| AZN | ASTRAZENECA PLC-ADR | 1.52% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.51% |
| STE | STERIS PLC | 1.46% |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1.45% |
| UNH | UNITEDHEALTH GROUP INC | 1.45% |
| JNJ | JOHNSON & JOHNSON | 1.45% |
| BBIO | BRIDGEBIO PHARMA INC | 1.42% |
| MRK | MERCK & CO. NEW | 1.40% |
| IQV | IQVIA HOLDINGS INC | 1.40% |
| SNN | SMITH & NEPHEW PLC | 1.39% |
| AMGN | AMGEN CORP | 1.39% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.35% |
| ZTS | ZOETIS INC | 1.34% |
| NVO | NOVO NORDISK A/S | 1.28% |
| BAX | BAXTER INTERNATIONAL INC | 1.25% |
| REGN | REGENERON PHARMACEUTICALS | 1.23% |
| MOH | MOLINA HEALTHCARE INC | 1.19% |
| DXCM | DEXCOM INC | 1.18% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.13% |
| IMVT | IMMUNOVANT INC | 1.09% |
| ELV | ELEVANCE HEALTH INC | 1.07% |
| MDRX | VERADIGM INC | 1.05% |
| BIIB | BIOGEN INC | 0.95% |
| RCKT | ROCKET PHARMACEUTICALS INC USD | 0.78% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.75% |
| HUM | HUMANA INC | 0.73% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.